|
|
 |
|
Viewing report
|
|
|
|
The Outlook for Pharmaceuticals in Northern Europe to 2013
Espicom Business Intelligence Ltd, May 2008
The countries of Northern Europe represent a total market of over 31.4 million people and a combined GDP of US$1.5 trillion in 2007. Each country report in this regional collection provides a comprehensive analysis of the pharmaceutical market, including five-year market forecasts. For each country you will receive 4 completely updated reports sent quarterly, plus comprehensive report sent annually.
The seven Northern European markets for pharmaceuticals are diverse, from the stable well-developed markets of Scandinavia to the less well-funded healthcare systems of the Baltic States. The countries covered by this regional collection represent a total pharmaceutical market value of US$16.0 billion. We forecast this figure will grow by US$4.3 billion over the next five years to US$20.3 billion!
The Outlook for Pharmaceutical Markets in Northern Europe is a unique collection of management reports from Espicom Business Intelligence. Each report provides individual and highly-detailed analysis of each market, looking at the key regulatory, political, economic and corporate developments in the wider context of market structure, service and access. The reports are available individually, or as a discounted collection, and prices include 4 completely updated reports sent quarterly, plus comprehensive report sent annually. There are over 65 markets covered in the worldwide series.
Customers who bought this item also bought
The Pharmaceutical Market: Netherlands
The Medical Device Market: USA
The Pharmaceutical Market: Pakistan
The Outlook for Pharmaceuticals in Northern Europe to 2013
The Pharmaceutical Market: Singapore
The Pharmaceutical Market: Ireland
The Pharmaceutical Market: Japan
The Pharmaceutical Market: Estonia
|
|
|
|
